NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials

NAFLD and nutraceuticals: a review of completed phase III and IV clinical trials

BackgroundNonalcoholic Fatty Liver Disease (NAFLD) has become a significant public health concern, affecting approximately one-fourth of the population. Despite its prevalence, no FDA-approved drug treatments specifically target NAFLD.AimTo provide a review of clinical trials investigating the use o...

Full description

Bibliographic Details
Main Authors: Omar E. Hegazi, Samer O. Alalalmeh, Ghala Rashid Humaid Alnuaimi, Moyad Shahwan, Ammar Abdulrahman Jairoun, Nasser M. Alorfi, Shaker A. Majrashi, Mustfa Faisal Alkhanani, Abdullah Alkhattabi, Mansour M. Alourfi, Faris A. Alsolami, Saeed Alsharif, Hatim Alshahrani
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Medicine
Subjects:
NAFLD
nutraceuticals
dietary supplements
Omega-3 fatty acids
vitamins
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1227046/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2023.1227046/full

Similar Items